Aspire Biopharma Holdings, Inc.

Aspire Biopharma Holdings, Inc., trading under the ticker PWUP, is a blank-check company with a focus on the biopharma and life sciences sector that filed an 8-K with the Securities and Exchange Commission on May 23, 2023, under accession number 0001104659-23-063676. Originally structured as a special purpose acquisition company targeting healthcare opportunities, PWUP is among the life sciences-focused vehicles that came to market during the active SPAC formation period of the early 2020s. The May 2023 filing reflects a material corporate disclosure event in the vehicle's lifecycle. For complete filing history, sponsor details, deal timelines, and analytic coverage on PWUP and the broader SPAC universe, sign up for full access at SpacDesk.